Jones Michael P, Koloski Natasha A, Walker Marjorie M, Holtmann Gerald J, Shah Ayesha, Eslick Guy D, Talley Nicholas J
School of Psychological Sciences, Macquarie University, North Ryde, New South Wales, Australia.
Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia.
Am J Gastroenterol. 2024 Sep 1;119(9):1894-1900. doi: 10.14309/ajg.0000000000002751. Epub 2024 May 14.
Disorders of gut-brain interaction (DGBIs) may originate in childhood. There are currently limited data on persistence of DGBI into adulthood and risk factors for persistence. Furthermore, there are no data on this question from general practice, where the majority of DGBIs are diagnosed and managed. This study documents the proportion of childhood-diagnosed DGBIs that persisted into adulthood and what factors were associated with persistence.
General practice records were obtained for more than 60,000 patients whose medical record spanned both childhood and adulthood years. Patients with diagnosed organic gastrointestinal disorder were excluded. Medical records were also interrogated for potential risk factors.
Eleven percent of patients with irritable bowel syndrome (IBS) and 20% of patients with functional dyspepsia (FD) diagnosed in childhood had repeat diagnoses of the same condition in adulthood. Female sex (odds ratio [OR] 2.02) was associated with persistence for IBS, while a childhood diagnosis of gastritis (OR 0.46) was risk-protective. Childhood non-steroidal anti-inflammatory drug use (OR 1.31, 95% confidence interval [CI] 1.09-1.56) was a risk factor for persistence in IBS. For FD, a childhood diagnosis of asthma (OR 1.30, 95% CI 1.00-1.70) was a risk factor, as was anxiety for both IBS (OR 1.24, 95% CI 1.00-1.54) and FD (OR 1.48 95% CI 1.11-1.97) with a similar finding for depression for IBS (OR 1.34, 95% CI 1.11-1.62) and FD (OR 1.88 95% CI 1.47-2.42).
Childhood DGBIs persist into adulthood in 10%-20% of patients, suggesting that management monitoring should continue into adulthood. Those diagnosed with anxiety or mood disorders in childhood should receive particular attention, and prescription of non-steroidal anti-inflammatory drugs in children should be made judiciously.
肠脑互动障碍(DGBIs)可能始于儿童期。目前关于DGBIs持续至成年期的数据有限,且对于持续存在的风险因素也知之甚少。此外,在大多数DGBIs得到诊断和管理的全科医疗领域,尚无关于此问题的数据。本研究记录了儿童期诊断的DGBIs持续至成年期的比例以及与持续存在相关的因素。
获取了60000多名病历涵盖儿童期和成年期的患者的全科医疗记录。排除已诊断为器质性胃肠疾病的患者。还对病历进行了潜在风险因素的调查。
儿童期诊断为肠易激综合征(IBS)的患者中有11%、功能性消化不良(FD)的患者中有20%在成年期被再次诊断为相同病症。女性(比值比[OR] 2.02)与IBS的持续存在相关,而儿童期诊断为胃炎(OR 0.46)具有风险保护作用。儿童期使用非甾体抗炎药(OR 1.31,95%置信区间[CI] 1.09 - 1.56)是IBS持续存在的一个风险因素。对于FD,儿童期诊断为哮喘(OR 1.30,95% CI 1.00 - 1.70)是一个风险因素,焦虑对于IBS(OR 1.24,95% CI 1.00 - 1.54)和FD(OR 1.48,95% CI 1.11 - 1.97)也是如此,IBS(OR 1.34,95% CI 1.11 - 1.62)和FD(OR 1.88,95% CI 1.47 - 2.42)的抑郁情况也有类似发现。
10% - 20%的儿童期DGBIs患者会持续至成年期,这表明管理监测应持续到成年期。儿童期被诊断为焦虑或情绪障碍的患者应受到特别关注,儿童非甾体抗炎药的处方应谨慎开具。